Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines

Although aberrant activation of the KRAS and PI3K pathway alongside TP53 mutations account for frequent aberrations in human gastric cancers, neither the sequence nor the individual contributions of these mutations have been clarified. Here, we establish an allelic series of mice to afford conditional expression in the glandular epithelium of Kras<sup>G12D</sup>;Pik3ca<sup>H1047R</sup> or Trp53<sup>R172H</sup> and/or ablation of Pten or Trp53. We find that Kras<sup>G12D</sup>;Pik3ca<sup>H1047R</sup> is sufficient to induce adenomas and that lesions progress to carcinoma when also harboring Pten deletions. An additional challenge with either Trp53 loss- or gain-of-function alleles further accelerated tumor progression and triggered metastatic disease. While tumor-intrinsic STAT3 signaling in response to gp130 family cytokines remained as a gatekeeper for all stages of tumor development, metastatic progression required a mutant Trp53-induced interleukin (IL)-11 to IL-6 dependency switch. Consistent with the poorer survival of patients with high IL-6 expression, we identify IL-6/STAT3 signaling as a therapeutic vulnerability for TP53-mutant gastric cancer.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2024-08-01
DOI
https://doi.org/10.1016/j.celrep.2024.114616
Citations
13
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
3.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines

Jennifer Huynh, Yang Liao, Ashleigh R. Poh, Amr H. Allam et al.
13 citations
Cell Reports
Cytokine Signaling Pathways and Interactions
3.67
article

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines

Jennifer Huynh, Yang Liao, Ashleigh R. Poh, Amr H. Allam, Moritz F. Eissmann, David Chisanga, Michael Büchert, Daniele V. F. Tauriello, Saumya P. Jacob, Stephen Forrow, Rita A. Busuttil, Matthias Ernst, Wei Shi, Stefan Thiem, David S. Williams, Eduard Batlle, Mariah Alorro, Alex Boussioutas, Joshua Konecnik, Anne Huber, Christine D. Dijkstra
article en
13 citations

Abstract

Although aberrant activation of the KRAS and PI3K pathway alongside TP53 mutations account for frequent aberrations in human gastric cancers, neither the sequence nor the individual contributions of these mutations have been clarified. Here, we establish an allelic series of mice to afford conditional expression in the glandular epithelium of Kras<sup>G12D</sup>;Pik3ca<sup>H1047R</sup> or Trp53<sup>R172H</sup> and/or ablation of Pten or Trp53. We find that Kras<sup>G12D</sup>;Pik3ca<sup>H1047R</sup> is sufficient to induce adenomas and that lesions progress to carcinoma when also harboring Pten deletions. An additional challenge with either Trp53 loss- or gain-of-function alleles further accelerated tumor progression and triggered metastatic disease. While tumor-intrinsic STAT3 signaling in response to gp130 family cytokines remained as a gatekeeper for all stages of tumor development, metastatic progression required a mutant Trp53-induced interleukin (IL)-11 to IL-6 dependency switch. Consistent with the poorer survival of patients with high IL-6 expression, we identify IL-6/STAT3 signaling as a therapeutic vulnerability for TP53-mutant gastric cancer.

Cell ReportsVol. 43(8)
Institució Catalana de Recerca i Estudis Avançats (ES), La Trobe University (AU), The Alfred Hospital (AU), Monash Alfred Psychiatry Research centre (AU), Institute for Research in Biomedicine (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Olivia Newton-John Cancer Wellness & Research Centre (AU), Austin Health (AU), Monash University (AU)
Good health and well-being
Openalex Percentile: Top 5%
Cytokine Signaling Pathways and Interactions
3.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.